These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6137373)

  • 1. What is the real pharmacological rationale for beta-receptor blocking agents?
    Biamino G; Schröder R
    Eur Heart J; 1983 Jul; 4 Suppl D():137-41. PubMed ID: 6137373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-Blockers in the management of myocardial ischemia.
    Davies RO
    Adv Cardiol; 1974; 13():315-29. PubMed ID: 4155918
    [No Abstract]   [Full Text] [Related]  

  • 3. A double-blind trial of penbutolol: a new beta-receptor blocking agent in the treatment of angina pectoris.
    Agarwal AK; Ahuja RC; Chandra M; Gupta NN; Hasan M
    J Int Med Res; 1976; 4(6):410-7. PubMed ID: 17557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of coronary disease with the beta-blocker betapressin].
    Christandl B
    Fortschr Med; 1981 Sep; 99(36):1473-6. PubMed ID: 6117510
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-adrenergic receptor blocking drugs in angina pectoris.
    Prichard BN
    Drugs; 1974; 7(1):55-84. PubMed ID: 4151695
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effectiveness of a new beta adrenergic blocking agent (penbutolol) in the treatment of ischemic cardiopathy].
    Ortuño Aznar F; Martín Jadraque L
    Med Clin (Barc); 1985 May; 84(19):766-8. PubMed ID: 2863437
    [No Abstract]   [Full Text] [Related]  

  • 7. Synergistic actions of nitrite-beta-adrenergic blocking agents in the therapy of angina pectoris. Pharmacologic and therapeutic rationale.
    Klein HO; Berger HJ
    Cardiology; 1973; 58(6):313-25. PubMed ID: 4153989
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative study of the effects of penbutolol and propranolol in the treatment of angina pectoris.
    Hillis WS; Tweddel AC; Murray RG; Lawrie TD
    Arzneimittelforschung; 1980; 30(9):1595-9. PubMed ID: 7006619
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effects of L-penbutolol and DL-propranolol. Comparison of the effects of these two drugs on conductivity and excitability in canine heart in vivo.
    Yamada K; Toyama J; Nimi N; Sugenoya J; Ohno M; Sugiyama S
    Jpn Heart J; 1979 Sep; 20(5):603-11. PubMed ID: 501926
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of tolamolol versus propranolol on cardiovascular haemodynamics in patients with angina.
    Aronow WS; March H; Vangrow JS; Cassidy J; Kern JC; Khemka M; Vawter M; Pagano J
    Br Heart J; 1974 Nov; 36(11):1078-81. PubMed ID: 4155953
    [No Abstract]   [Full Text] [Related]  

  • 11. Beta-adrenoceptor blocking effects and pharmacokinetics of betaxolol (SL 75212) in man.
    Giudicelli JF; Chauvin M; Thuillez C; Richer C; Bianchetti G; Gomeni R; Morselli PL
    Br J Clin Pharmacol; 1980 Jul; 10(1):41-9. PubMed ID: 6104973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jul; 20(1):1-23. PubMed ID: 6105067
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological and clinical aspects of drug therapy in coronary heart disease: clinical aspects of therapy with beta-adrenoceptor antagonists.
    Prichard BN
    Z Kardiol; 1990; 79 Suppl 3():99-103. PubMed ID: 1983055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of beta adrenergic blocking agents in the management of the patient with acute myocardial infarction.
    Arensberg D
    Prim Care; 1981 Sep; 8(3):461-6. PubMed ID: 6118904
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of coronary insufficiency with beta-receptor antagonists (author's transl)].
    Hitzenberger G
    Arzneimittelforschung; 1977; 27(3a):700-2. PubMed ID: 17414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Comparison of the effect of a selective and a nonselective beta receptor blocker on the ischemic ST segment, lung function and stress-induced decrease in blood glucose].
    Brügmann U; Blasini R
    Herz; 1986 Feb; 11(1):55-61. PubMed ID: 2870014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha- and beta-blockade in angina pectoris.
    Taylor SH
    Drugs; 1984; 28 Suppl 2():69-87. PubMed ID: 6151892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Beta receptor blockers and calcium antagonists in coronary disease. Differential therapeutic aspects].
    Delius W
    Dtsch Med Wochenschr; 1983 Jul; 108(30):1154-8. PubMed ID: 6140156
    [No Abstract]   [Full Text] [Related]  

  • 19. The conundrum of the effect of beta-blockade on myocardial oxygen consumption.
    Illes RW; Silverman NA; Krukenkamp IB; Levitsky S
    J Surg Res; 1988 Apr; 44(4):336-41. PubMed ID: 2896274
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of adrenergic beta blockers on hemodynamics, diastolic relaxation and distensibility of left-ventricular myocardium in patients with ischemic heart disease].
    Moroz VA; Gladchenko AR; Latoguz IK; Khimenko PL
    Klin Med (Mosk); 1991 Jan; 69(1):47-8. PubMed ID: 1673730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.